Skip to main content
U2BIO CO., LTD. logo

U2BIO CO., LTD. — Investor Relations & Filings

Ticker · 221800 ISIN · KR7221800006 KO Human health and social work activities
Open in API
Filings indexed 227 across all filing types
Latest filing 2026-01-12 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 221800

About U2BIO CO., LTD.

https://www.u2bio.co.kr/eng/main.do

U2BIO CO., LTD. is a healthcare technology company specializing in the integration of biotechnology (BT) and information technology (IT). The company provides a range of in vitro diagnostic services, including clinical laboratory tests and molecular diagnostics. Concurrently, it develops and offers digital healthcare solutions and medical IT services tailored for medical institutions such as hospitals and clinics. U2BIO focuses on delivering personalized healthcare services based on scientific data to support medical professionals and improve patient health outcomes.

Recent filings

Filing Released Lang Actions
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange, specifically detailing a 'Decision on Paid-in Capital Increase' (유상증자결정). It outlines the issuance of new shares via third-party allocation, the purpose of the capital (acquisition of securities), pricing methodology, and board resolution details. This falls under the category of announcements regarding new share issues and capital structure changes.
2026-01-12 Korean
주요사항보고서(타법인주식및출자증권양수결정)
Capital/Financing Update Classification · 98% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korea Exchange (KRX) regarding the acquisition of shares in another company (타법인 주식 및 출자증권 양수결정). This type of filing is a mandatory regulatory disclosure concerning corporate transactions, capital structure changes, and investment decisions. It does not fit into specific categories like earnings releases, annual reports, or proxy statements, and is best classified under the general regulatory filing category for corporate disclosures.
2026-01-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Lee Jaewoong) in the company 'U2Bio'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant changes in ownership levels that cross reporting thresholds.
2026-01-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. This type of filing is specifically used to report changes in share ownership by insiders (directors or major shareholders), which corresponds to the 'Director's Dealing' (DIRS) category in the provided schema.
2026-01-09 Korean
타법인주식및출자증권취득결정
Capital/Financing Update Classification · 98% confidence The document is a regulatory filing regarding the acquisition of shares in another company (SML Meditree) by U2Bio. This type of disclosure, involving the acquisition of equity in another entity, is classified as M&A activity (Mergers and Acquisitions) within the provided taxonomy, as it details the purchase of shares, the purpose of the acquisition, and the financial status of the target company.
2026-01-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/Korea Exchange). This type of filing is a standard regulatory requirement for insiders (directors/executives) to disclose their shareholdings and changes therein. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers reports of personal share transactions and ownership status by company directors and executives.
2026-01-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.